Search

everythinglearnresearchcommunity

for

Search:↓

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Sweet syndrome can be the only sign of hairy cell leukemia relapse.

Blood tests can detect ovarian Leydig cell tumors when scans don't, and surgery can confirm and treat these tumors.

Cell-mediated drug delivery systems improve skin disease treatment by using living cells for precise, prolonged, and less toxic therapy.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

An ovarian tumor caused a woman's male-like symptoms, which improved after surgery.

A 90-year-old woman's hand lesion was a rare, aggressive skin cancer treated successfully with surgery.

Finasteride is effective for male hair loss, teledermatology is accurate and accepted, and cyclosporin helps treat toxic epidermal necrolysis.

Scalp melanoma is more common and easier to diagnose early in people with androgenetic alopecia due to sun damage.

Erlotinib can cause persistent excessive hair growth.

Keeping radiation doses under 16 Gy may reduce permanent hair loss.

Early treatment of EPDS can improve outcomes and reduce recurrence risk.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

EPDS can cause recurring scalp sores and hair loss if not treated.

Low CD4 counts in HIV patients are linked to more skin disorders.

Consider TFI in facial hypopigmentation diagnoses and confirm with a biopsy.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

No increased skin cancer risk was found in alopecia patients treated with photobiomodulation.

Some existing medicines show promise as safe treatments to protect against the side effects of radiation therapy.

New skin lesions on the scrotum or vulva in patients with a history of internal cancer could indicate rare skin metastasis.

A 91-year-old woman's hair turned black in one spot, with skin changes underneath.

Keratoacanthoma and some squamous cell carcinomas are linked to hair follicles, while others are not.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Hair turning darker can be a sign of skin cancer.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

Some medications and supplements can cause serious side effects, including hair loss, heart rhythm problems, liver injury, and other health issues.

Malignant eye tumors produce more silver nanoparticles than benign ones.

Hair repigmentation can indicate malignancy and should be investigated.

PRAME helps distinguish between benign and malignant skin cells in most cases.

High proliferative activity and peripheral invasion indicate malignancy in canine sebaceous gland tumors; the term 'epithelioma' should be updated for clarity.